{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:54:39Z","timestamp":1785768879214,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejogrb.2016.07.489","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T13:57:31Z","timestamp":1470319051000},"page":"105-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF"],"prefix":"10.1016","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5412-2551","authenticated-orcid":false,"given":"Henri","family":"Marret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fauconnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Dubernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Misme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lagarce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Lesavre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Mimoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Tourette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Curinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Rabishong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubert","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2016.07.489_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jgyn.2014.12.008","article-title":"Evidence-based evaluation and expertise of methotrexate off label use in gynaecology and obstetrics: work of the CNGOF","volume":"44","author":"Marret","year":"2015","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","article-title":"The levels of evidence and their role in evidence-based medicine","volume":"128","author":"Burns","year":"2011","journal-title":"Plast Reconstr Surg"},{"issue":"November (7 Suppl.)","key":"10.1016\/j.ejogrb.2016.07.489_bib0015","first-page":"S109","article-title":"Coll\u00e8ge National des Gyn\u00e9cologues et Obst\u00e9triciens Fran\u00e7ais. [Ectopic pregnancy management. Guidelines]","volume":"32","year":"2003","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/GRF.0b013e3182510a35","article-title":"Methotrexate the pharmacology behind medical treatment for ectopic pregnancy","volume":"55","author":"Stika","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0025","first-page":"778","article-title":"The medical management of ectopic pregnancy: a meta-analysis comparing single dose and multidose regimens","volume":"101","author":"Barnhart","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/01443610802163773","article-title":"Is routine monitoring of hepatic and renal function beneficial following single-dose methotrexate treatment for ectopic pregnancy? A 4-year review of experience from a teaching hospital","volume":"28","author":"Darbhamulla","year":"2008","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0035","first-page":"754","article-title":"Single-dose methotrexate for treatment of ectopic pregnancy","volume":"77","author":"Stovall","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0040","first-page":"749","article-title":"Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases","volume":"77","author":"Stovall","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdra.23003","article-title":"Teratogen update: methotrexate","volume":"94","author":"Hyoun","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.07.489_bib0050","article-title":"Interventions for tubal ectopic pregnancy","author":"Hajenius","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0029-7844(96)00293-1","article-title":"Low-dose oral methotrexate with expectant management of ectopic pregnancy","volume":"88","author":"Korhonen","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0060","first-page":"431","article-title":"Fertility after ectopic pregnancy: 10-year results in the Auvergne registry","volume":"32","author":"Bouyer","year":"2003","journal-title":"J Gyn\u00e9col Obst\u00e9t Biol Reprod"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0065","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/humrep\/det037","article-title":"Fertility after ectopic pregnancy: the DEMETER randomized trial","volume":"28","author":"Fernandez","year":"2013","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn012","article-title":"Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis","volume":"14","author":"Mol","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0029-7844(96)00370-5","article-title":"Methotrexate prophylaxis for persistent ectopic pregnancy after conservative treatment by salpingostomy","volume":"89","author":"Graczykowski","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0015-0282(01)02906-5","article-title":"Prophylactic methotrexate after linear salpingostomy: a decision analysis","volume":"76","author":"Gracia","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0085","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1034\/j.1600-0412.2002.811110.x","article-title":"Persistent ectopic pregnancy after linear salpingotomy: a non-predictable complication to conservative surgery for tubal gestation","volume":"81","author":"Lund","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0015-0282(16)57291-4","article-title":"Ultrasound-guided injection of methotrexate versus laparoscopic salpingotomy in ectopic pregnancy","volume":"3","author":"Fernandez","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0095","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.fertnstert.2003.09.070","article-title":"Previous ectopic pregnancy as a predictor of failure of systemic methotrexate therapy","volume":"81","author":"Lipscomb","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0100","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/uog.13255","article-title":"Predictive value of hemoperitoneum for outcome of methotrexate treatment in ectopic pregnancy: an observational comparative study","volume":"43","author":"Gnisci","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0020-7292(99)00114-9","article-title":"Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate","volume":"67","author":"Elito","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0110","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/oxfordjournals.humrep.a137476","article-title":"The use of a pretherapeutic, predictive score to determine inclusion criteria for the non-surgical treatment of ectopic pregnancy","volume":"6","author":"Fernandez","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0115","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0015-0282(16)57055-1","article-title":"Treatment of unruptured tubal pregnancy with methotrexate: pharmacokinetic analysis of local versus intramuscular administration","volume":"62","author":"Fernandez","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijgo.2012.11.020","article-title":"Single-dose methotrexate injection for treatment of ectopic pregnancy in women with relatively low levels of human chorionic gonadotropin","volume":"121","author":"Krissi","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"issue":"341","key":"10.1016\/j.ejogrb.2016.07.489_bib0125","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1056\/NEJM199912233412604","article-title":"Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies","volume":"23","author":"Lipscomb","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.fertnstert.2010.08.025","article-title":"Predictive factors of failure in management of ectopic pregnancy with single-dose methotrexate: a general population-based analysis from the Auvergne register, France","volume":"95","author":"Rabischong","year":"2011","journal-title":"Fertil Steril"},{"issue":"January","key":"10.1016\/j.ejogrb.2016.07.489_bib0135","article-title":"Nonsurgical management of live tubal ectopic pregnancy by ultrasound-guided local injection and systemic methotrexate","volume":"23","author":"Wang","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0140","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/humrep\/17.12.3224","article-title":"Sites of ectopic pregnancy; a 10year population-based study of 1800 cases","volume":"17","author":"Bouyer","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0145","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1471-0528.2004.00442.x","article-title":"The conservative management of interstitial pregnancy","volume":"111","author":"Jermy","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0150","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/01.AOG.0000262052.09350.52","article-title":"Transvaginal ultrasoundguided treatment of cervical pregnancy","volume":"109","author":"Jeng","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0155","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.fertnstert.2007.12.054","article-title":"Conservative management of cervical ectopic pregnancy","volume":"91","author":"Verma","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajog.2012.03.007","article-title":"Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A review","volume":"207","author":"Timor-Tritsch","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"44","key":"10.1016\/j.ejogrb.2016.07.489_bib0165","first-page":"e1","article-title":"The diagnosis, treatment, and follow-up of cesarean scar pregnancy","volume":"207","author":"Timor-Tritsch","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2011.11.026","article-title":"Caesarean scar pregnancy: comparative efficacy and safety of treatment by uterine artery chemoembolization and systemic methotrexate injection","volume":"161","author":"Wu","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.07.489_bib0175","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejogrb.2003.09.038","article-title":"Ovarian pregnancy a 12year experience of 19 cases in one institution","volume":"114","author":"Raziel","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0180","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.fertnstert.2010.09.006","article-title":"Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome","volume":"95","author":"Barnhart","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0185","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/humrep\/dem073","article-title":"Rationalizing the follow-up of pregnancies of unknown location","volume":"22","author":"Kirk","year":"2007","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijgo.2004.04.004","article-title":"Human chorionic gonadotrophin and progesterone levels in pregnancies of unknown location","volume":"86","author":"Condous","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0195","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/uog.4015","article-title":"Prediction of ectopic pregnancy in women with a pregnancy of unknown location","volume":"29","author":"Condous","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/humrep\/des373","article-title":"Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison","volume":"28","author":"Van Mello","year":"2013","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.ejogrb.2016.07.489_bib0205","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/humrep\/deg344","article-title":"Medical treatment of ectopic pregnancies: a randomized clinical trial comparing methotrexate-mifepristone and methotrexate-placebo","volume":"18","author":"Rozenberg","year":"2003","journal-title":"Hum Reprod Oxf Engl"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516308168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516308168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:36:45Z","timestamp":1759556205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211516308168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":41,"alternative-id":["S0301211516308168"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.07.489","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.07.489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}